Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Mar 19;17:219–236. doi: 10.2147/JAA.S342391

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 Panettieri Jr et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

AAER during each season in patients with any seasonal aeroallergen sensitization/allergy overall (A), with baseline BEC <300 cells/μL (B), and with baseline BEC ≥300 cells/μL (C), receiving tezepelumab 210 mg Q4W or placebo. A post hoc analysis of the NAVIGATOR Phase 3 study.

Notes: Calendar seasons were defined as winter (January to March), spring (April to June), summer (July to September), and fall (October to December).

Abbreviations: AAER, annualized asthma exacerbation rate; BEC, blood eosinophil count; FEIA+, fluorescence enzyme immunoassay positive; Q4W, every 4 weeks.